Vasculitis refers to heterogenous clinicopathologic disorders that share the histopathology of inflammation of blood vessels. When unrecognized and therefore untreated, vasculitis of the nervous system leads to pervasive injury and disability making this a disorder of paramount importance to all clinicians.
Introduction
Vasculitis is a spectrum of clinicopathological disorders defined by inflammation of the blood vessels, including arteries and veins of varying caliber, which result in a variety of clinical neurological manifestations related to ischemic injury of the central nervous system (CNS) and peripheral nervous system (PNS). This article reviews the remarkable progress that has been made in the pathogenesis, classification, diagnosis, and management of vasculitis of the nervous system. Several excellent reviews have been published on this topic [1 . ,2].
Classification
Vasculitis in its various forms affects blood vessels of varying caliber from the aorta to capillaries and veins ( Fig. 1) . The diverse forms of vasculitis and autoimmune diseases to be considered in this chapter are summarized in Table 1 .
Systemic necrotizing arteritis of the polyarteritis nodosa type
Polyarteritis nodosa (PAN) is the prototypic disorder of the group of systemic necrotizing arteritis, which also includes Churg-Strauss syndrome, microscopic polyangiitis (MPA) syndrome, Kawasaki disease and an overlap syndrome.
The early history of vasculitis is debatable, but one fact is clear, the ealiest patients with vasculitis had PAN and neurological involvement, such as the patient described by Kussmaul and Maier in 1886 [3] , who presented with leg pains, cramps, and tenderness so prominent that trichinosis was contemplated. At postmortem examination there was widespread arteritis that resembled syphilitic periarteritis caused by the frequent occurrence of internal and external elastic lamina necrosis, fibrin deposition, aneurysmal dilatations, and intimal proliferation resulting in endarteritis obliterans of the brain, nerves, skeletal muscle, and in systemic organs of small and medium size vessels with a diameter of 120 mm or more (Fig. 2) . Peripheral neuropathy is the most frequent finding, typically mononeuritis multiplex (MNM) caused by involvement of the arteriae nervorum, followed by CNS manifestations of two types, one resulting from stroke and cerebral hemorrhage ( Fig. 3 ) and the second a diffuse encephalopathy accompanied by seizure phenomena. The arteritis of MPA affects small arterioles, capillaries, and venules of the kidney and lungs; 50-80% of patients have circulating antineutrophil cytoplasmic antibodies (ANCA) to myeloperoxidase or perinuclear ANCA. Kawasaki disease is characterized by viral exanthema that ultimately leads to PAN, focused primarily in the coronary arteries. In 1951, Churg and Strauss [4] delineated a syndrome of asthma, eosinophilia, extravascular granulomas and necrotizing arteritis, involving arterioles, capillaries, and venules that was named in their honor. The extravascular granulomas, epithelioid and giant cell infiltrates distinguish Churg-Strauss syndrome from classic PAN and resemble MPA in the tendency to involve the lung and kidney. Early suspected patients present with allergic rhinitis, nasal polyposis, and asthma, followed by tissue eosinophilia and systemic vasculitis, with CNS involvement that includes confusion, seizures, cranial nerve involvement, optic neuropathy, and less common radicular and plexus PNS manifestations.
Hypersensitivity vasculitis
Historically, in the same period as PAN, Zeek et al. [5] described patients with sensitivity to sulfonamides and other drugs that manifested with skin rash and generalized vasculitis. So-called hypersensitivity vasculitis includes syndromes related to drug reactions, HenochSchö nlein purpura, hypocomplementemic or urticarial vasculitis and cryoglobulinemia. These disorders demonstrate non-segmental infiltration of the walls of small vessels and postcapillary venules, particularly of the dermis and other systemic tissue by polymorphonuclear leukocytes (PMN), which disintegrate leaving nuclear fragments or leukocytoclastic vasculitis (LCV) (Fig. 4) , fibrinoid necrosis, micro-infarction and hemorrhages of affected tissues, including those of the nervous system.
Drug reactions are responsible for approximately 20% of cases of dermal vasculitis usually associated with immune complex deposition, and abates with drug withdrawal and all other possibly offending agents. Affected patients present with 'flu-like constitutional signs that include fever and headache, and progresses to skin lesions, and if serious or advanced enough, seizures, encephalopathy, stroke, cranial nerve signs, and myelopathy. In contrast to PAN, lesions are in the same stage of evolution.
Henoch-Schö nlein purpura is characterized by nonthrombocytopenic purpura, arthralgia, abdominal pain, LCV, and IgA immune complex deposition with complement activation in affected children. It is characterized histopathologically by varying degrees of arteriolar, capillary, and venular interstitial infiltration by PMN cells, eosinophils, and mononuclear cells, with variable fibrinoid necrosis and perivascular granuloma formation. Affected children present with fever, urticaria, arthralgia, lymphadenopathy, and headache and abdominal pain so severe as to suggest meningitis and acute surgical abdomen, usually after injection with heterologous antiserum.
Hypocomplementemic or urticarial vasculitis is characterized by urticaria, migratory arthralgia, angioneurotic edema, and systemic laryngeal, renal, abdominal, and splenic involvement, in middle-aged women. Tissue biopsies showed immune complexes, with binding of IgG and IgM to C1q along basement membranes, which leads to complement activation, with normal C1 esterase inhibitor levels.
Cryoglobulins are substances composed of IgG and IgM, complement, lipoprotein, and antigenic moieties that precipitate at temperatures below 378C, which in serum excess lead to hyperviscosity. Their detection of circulating cryoglobulin leads to consideration of one of the three recognized clinical types, based on whether the single monoclonal antibody is of the IgM or IgG type, mixed, or with activity against polyclonal IgG, and associated with lymphoproliferative disorders and hepa- Figure 2 . This small muscular artery from muscle is from a patient with polyarteritis nodosa
In the third, or proliferative, phase illustrated here, chronic inflammatory cells replace the neutrophils of the second phase, there is evidence of necrosis of the media (arrows), early intimal proliferation (arrowheads), and fibrosis. The lumen is almost completely occluded. Ultimately, in the healing phase, this process is replaced by dense, organized connective tissue (stain, hematoxylin and eosin; original magnification 6250). Reproduced from Younger [1 . ] with permission of the publisher.
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Systemic granulomatous vasculitis
Granulomatous vasculitis consists of several clinicopathological disorders (Fig. 1) , including Wegener granulomatosis (WG), lymphomatoid granulomatosis, and lethal midline granulomas.
In 1951, Godman and Churg [6] described a triad of necrotizing granulomatous lesions of the sinuses and lower respiratory tract, with systemic necrotizing vasculitis of the small arteries and veins, and glomerulonephritis. The lesions of WG begin as minute foci of granular necrosis and fibrinoid degeneration with PMN cells, followed by histiocytes and giant cells along the margins of granulomas of the upper airways and in renal glomeruli. Necrotizing granulomatous lesions secondarily involve small arteries, arterioles, capillaries, and venules with segmental fibrinoid necrosis in the tissues involved (Fig. 5 ). Neurological manifestations occur as a result of systemic vasculitis, granulomatous invasion and extension from the upper airway and remote granulomatous disease. Affected patients often present with multifocal pain, sensory loss, and weakness caused by MNM that can ultimately become disabling. CNS involvement is of several types depending upon whether there is vasculitic, contiguous extension, or remote granulomatous spread. Stroke, intracerebral and subarachnoid hemorrhage, and optic neuritis can result from vasculitis of the anterior and posterior ciliary and retinal vessels. Contiguous extension from nasal and paranasal sinus cavity granulomas can occur through the orbit leading to pseudotumor with exophthalmos, or may involve extraocular muscles, optic and oculomotor nerves, whereas extension through the temporal bone can destroy the middle ear. Patients with WG have circulating ANCA specific for proteinase-3 or circulating ANCA.
Lymphomatoid granulomatosis is an inflammatory malignant lymphoreticular disorder that results from angiocentric and angiodestructive lesions of small and medium-sized muscular arteries and their endothelia (Fig. 6 ). Infiltration by unifocal and multifocal necrotizing, inflammatory masses occurs in systemic organs and the CNS usually without fibrinoid necrosis or LCV. Focal neurological involvement stems from the invasion of the CNS by unifocal and multifocal necrotizing inflammatory masses of the cerebrum, brain stem, cerebellar parenchyma, and meninges, usually associated with chest lesions, which raises the suspicion of WG, sarcoidosis, fungal and mycobacterial infection. Lethal midline granuloma is a destructive and often fatal vasculitis of major midline structures of the head. Historically, this disorder was likened to WG, but systemic disease is not a major feature as in WG, and the latter rarely causes facial mutilation. Neurological manifestations result from direct invasion of the orbit and face, jugular vein, sigmoid and cavernous sinus leading to vascular thrombosis, sepsis, meningitis, and exsanguination.
Giant cell arteritis
The concept of giant cell (temporal) arteritis was first described in 1937 by Horton et al. [7] , and was later named for the site of granulomatous giant cell inflammation and vessel involvement by Jennings [8] . Patients with biopsy-confirmed temporal arteritis and associated blindness as a result of the involvement of the ophthalmic and posterior ciliary artery were classified as having cranial arteritis; whereas those with prominent constitutional and musculoskeletal complaints, without neurological involvement, were deemed to have polymyalgia rheumatica. Patients with giant cell lesions along the aorta, its branches, and in other medium and largesized arteries at autopsy warranted the diagnosis of generalized giant cell arteritis. Temporal arteritis is primarily related to disease along the ophthalmic, posterior ciliary, superficial temporal, occipital, facial, and internal maxillary arteries, primarily in old individuals of either sex. This leads to headache, jaw claudication, scalp tenderness, thickened, nodular, or pulseless temporal artery, which if untreated results in visual loss as a result of ischemic optic neuritis.
Takayasu arteritis involves the elastic branches of the aorta and its major extracranial vessels in adolescent girls and women, typically 50 years of age or younger. The inflammatory cell infiltrate in temporal arteritis and Takayasu arteritis is comprised of activated T cells, macrophages, and multinucleated giant cells, often arranged in granulomas, close to the fragmented internal elastic membrane [9 . . ]. Intimal hyperplasia leads to concentric thrombosis and occlusion of the vessel lumen, which in Takayasu arteritis, can lead to vessel dilation and aneurysm formation (Fig. 7) . Neurological sequelae occur late in the obliterative phase of the disease as a result of chronic ischemia of the ascending or descending aorta or its major branches, as manifested by headache, orthostatic dizziness, syncope, stroke, amaurosis fugax, monocular blindness, optic nerve atrophy, and corneal opacification.
Granulomatous angiitis of the nervous system
The concept of a vasculitis with a unique predilection for the CNS emerged in 1959 with the classic description by Cravioto and Fegin [10] of granulomatous angiitis of the nervous system (GANS), and with it problems of nomenclature for decades to come. Before its formal delineation as a distinct clinicopathological entity, there was difficulty in separating it from polyarteritis and syphilitic endarteritis because of the occasional finding of vascular necrosis, giant cells and epithelioid cells in those disorders. The association with varicella zoster virus (VZV) infection, lymphoproliferative tumors, sarcoidosis, amyloid angiopathy, and HIV infection has demonstrated the clinical heterogeneity. The pathological heterogeneity has been exemplified by its variability in the predilection for vessels of varying sizes, from small leptomeningeal to large named cerebral vessels (Fig. 8 ) [11] . Headache, mental change, and cerebrospinal fluid (CSF) pleocytosis with protein content above 75 mg/dl are noted in virtually all cases, leading to uncertainty in the diagnosis in the absence thereof. Unrecognized and therefore untreated, up to half the patients develop focal signs, seizures, aphasia, and hemiparesis, progressing to tetraparesis, and coma ( Fig. 9 ). Granulomatous angiitis in association with VZV infection, lymphoma, sarcoidosis, giant cell arteritis, amyloid angiopathy, and HIV infection carries a similarly severe prognosis.
The etiology of granulomatous angiitis is not well understood, but a brain and meningeal biopsy are the gold standard for diagnosis. The preferred site is the temporal tip of the non-dominant hemisphere, so guided by the results of neuroimaging and angiography. Neurologists have had to decide the course of therapy of patients with GANS without the benefit of controlled trials, and with bias in the literature that has long favored the administration of combined prednisone and cyclo- phosphamide therapy. Common sense dictates that cyclophosphamide at least be reserved for pathologically confirmed patients who fail to improve or progress when taking prednisone, and can be safely monitored for potentially serious medication side-effects [12] .
Connective tissue disorders
The earliest concepts of the collagen vascular or connective tissue disorders stemmed from the appreciation of fibrinoid necrosis using collagen staining in patients with systemic lupus erythematosus (SLE). Necrotizing and non-necrotizing vasculitis occurs in SLE, scleroderma, rheumatoid arthritis, Sjö gren syndrome, mixed connective tissue disease, and Behçet disease.
Systemic lupus erythematosus
SLE is a multisystem autoimmune disorder, with protein dermal, joint, renal, cardiac, and hematological manifestations. Vasculitis occurs in 10-15% of patients at some time, often in the first year of diagnosis, most often optic neuropathy, transverse myelitis, headache, stroke, and pseudotumor cerebri caused by venous sinus thrombosis, myelopathy, chorea, neuropathy, dementia, and affective disorders. Once thought to be an important cause of cerebral lupus, true vasculitis with disruption of the vessel walls and internal elastic lamina and muscular necrosis is exceedingly rare, and should be eschewed especially in those with encephalopathy and stroke, unless there is frank systemic vasculitic involvement. However, when present, cerebral vasculitis results from fibrinoid necrosis of the small arteries, arterioles, and capillaries, with fibrinoid necrosis of collagen fibers, which swell, fragment, and later dissolve in the course of the disease (Fig. 10) . The resulting homogenous hyaline material contains immunoglobulins, antigen-antibody complexes, complement, and fibrinogen. Non-vasculitic cerebral vasculopathy in SLE may be caused by circulating IgG and IgM antiphospholid antibodies, which demonstrate procoagulant activity with prolongation of the activated partial thromboplastic time. The enzyme-linked immunosorbent assay (anticardiolipin antibody test), using cardiolipin as the antigenic probe for antiphospholid antibodies, is abnormal in more than 50% of patients with SLE, and in high titers, especially anticardiolipin IgG, heightens the risk of occlusive cerebral events in cohorts matched for age-related risk of stroke (Fig. 11) . A catastrophic syndrome occurs with SLE with or without a history of antiphospholid antibodies, which is rapidly fatal unless treated promptly with plasmapheresis and anticoagulation.
Scleroderma
Scleroderma or systemic sclerosis is characterized by widespread microvasculopathy and diffuse tissue fibrosis affecting the skin and other systemic organs, particularly the heart, lungs, and gastrointestinal tract. Central and peripheral neuromuscular manifestations including headache, encephalopathy, seizures, and myositis, and follow the onset of renal involvement with the development of malignant high renin hypertension, and the CREST syndrome, named for Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia, often in association with interstitial lung disease. Systemic necrotizing arteritis develops in less than 1% of cases, and can be indolent or can resemble PAN with systemic sclerosis, CREST, dermal vasculitis, stroke, and MNM (Fig. 12) . Microvascular disease in scleroderma appears to be mediated by at least three autoantibodies, those against centromere, SCL-70 or topoisomerase, RNApolymerase III determinants, and the HLA-DQB1 haplotype.
Rheumatoid arthritis
Rheumatoid arthritis is a multisystemic nodular, granulomatous disease with prominent constitutional and multiorgan involvement including the nervous system. Rheumatoid lesions begin as proliferative joint synovitis with infiltration of T cells and plasma cells and scattered areas of fibrinoid necrosis. Neutrophils contribute to tissue destruction through the release of lytic enzymes and the production of toxic oxygen free radicals. The inflammatory infiltrate increases in size with nodule formation with a predilection for serous membranes, or may take the form of sheet-like plaques of necrosis and inflammation in the nervous system at sites of connective tissue investment, such as the dura, muscle, and nerve. Rheumatic pachymeningitis results from dural, leptomeningeal plaques, and nodules containing lymphocytic inflammation and fibrinoid material that predisposes to seizures, cerebral hemorrhage, encephalopathy and myelopathy. The erosive skeletal manifestations include atlantoaxial, odontoid, atlantoaxial and subaxial subluxation; vertebral collapse, and canal stenosis resulting from extradural pannus that leads to spastic quadriparesis.
Sjö gren syndrome
Sjö gren syndrome is recognized by keratoconjunctivitis sicca, xerostomia, and frequent association with other connective tissue disorders such as SLE, scleroderma, essential mixed cryoglobulinemia, accompanied by lymphoid invasion of the exocrine tissues throughout the body, rarely in renal institium and muscle. 
Inflammatory diabetic vasculopathy
The frequency of necrotizing arteritis in diabetic nerves is not known, but as there are only a handful of reported cases, two of which were reported by this author [13] , the occurrence of vasculitic diabetic neuropathy is probably exceedingly rare. Non-necrotizing vasculopathy has been noted for decades, but only recently has its significance been appreciated. Peripheral nerve perivasculitis, defined as inflammation around the walls of epineurial vessels, and microvasculitis, in which inflammation invades epineurial vessel walls, occurs in the majority of patients, with severe distal symmetrical sensorimotor, proximal diabetic neuropathy, lumbosacral plexopathy, and diabetic MNM (Fig. 13) . The biopsied nerves of such patients, studied intensively by a panel of monoclonal antibodies against lymphocyte cell determinants and inflammatory markers, reveal a predominance of CD8 cytotoxic suppressor cells in the vascular inflammatory infiltrate, with the expression of IL-2, nerve growth factor receptor, and a-IFN, and abnormal activation of C5b-9 membrane attack complex (MAC), consistent with an autoimmune pathogenesis of the neuropathy in such cases [14] .
Isolated peripheral nerve vasculitis
Peripheral neuropathy may rarely be the singular manifestation of necrotizing arteritis, as demonstrated in a nerve and muscle biopsy specimen without evidence of systemic necrotizing vasculitis in life or at postmortem examination. Some authorities, including the author, question the premise of an isolated peripheral nerve vasculitis, citing several lines of evidence. First, the absence of long-term follow-up in most cases, with only a single autopsy-confirmed patient reported more than 60 years ago [15] . Second, the finding of systemic vasculitis in up to two-thirds of patients with histologically confirmed peripheral nerve vasculitis, usually forme fruste of PAN, WG type, or in association with another definable dysimmune disease such as rheumatoid arthritis, Sjö gren syndrome, SLE, scleroderma, monoclonal gammopathy, or mixed connective tissue disease type.
Central nervous system vaculitis caused by infection
Vasculitis and headache occurs early in the setting of infection by several possible mechanisms. VZV, the spirochetes Treponema pallidum and Borrelia burgdorferi, several fungal agents, and Rickettsiae invade cerebral blood vessels causing CNS vasculitis. Bacteria and mycobacteria cause indirect damage to cerebral blood vessels in fulminant meningitis as they traverse purulent exudate in cisterns at the base of the brain, and along foci of cerebritis. Cerebral vessel damage occurs in association with hepatitis C viral infection through the production of cryoglobulins and cryoprecipitate comprised of immunoglobulin, complement, lipoprotein, and hepatitis C viral antigen; as well as immune complex deposition, cold agglutinin formation, intravascular activation of complement and clotting factors, and vascular endothelial cell proliferation. HIV-1 infection causes neurological vasculitic complications as a result of opportunistic infection and HIV itself.
Varicella zoster virus
Herpes zoster ophthalmicus caused by VZV infection is associated with headache and delayed contralateral hemiparesis as a result of granulomatous vasculitis ipsilateral to skin lesions, especially in immunocompromised patients. In pathologically studied cases, necrotizing arteritis and thrombosis is noted with viral particles and antigens isolated in the media of affected vessels.
Spirochete infection
Two spirochete infections lead to vasculitis of the nervous system, as described below.
Treponema pallidum
Spirochetes enter the host through a skin or mucous membrane site, with wide dissemination to multiple organs including the CNS, with latent reactivation and cerebral vessel involvement leading to headache and vasculitis. One to 2 years after asymptomatic neurosyphilis caused by CNS seeding by T. pallidum, acute syphilitic meningitis presents with headache, meningeal signs, cranial nerve palsies, seizures, and other focal deficits. Meningovascular syphilis, which occurs in approximately 10% of patients, presents with headache, vertigo, behavioral, and mood changes that last weeks to months, and stroke in the setting of meningeal involvement. The vasculitis is believed to result from spirochetal invasion of vascular endothelial cells. Cerebral vessel involvement occurs years later in tertiary parenchymal syphilis syndrome of general paresis and tabes dorsalis, in which there is considerably more neuronal degeneration and gummas indicative of chronic inflammation are present.
Borrelia burgdorferi
The spirochete B. burgdorferi is transmitted by the bite of an infected tick leading to characteristic skin, joint, heart, eye, and nervous system involvement. Lyme neuroborreliosis presents with Garin's triad of headache, neuritis, meningitis, and radiculitis. Cerebrovascular manifestations include vasculitis in association with headache, stroke, transient ischemic attack, and subarachnoid hemorrhage caused by focal mononuclear inflammatory cell infiltration of blood vessels, with vascular endothelial cell swelling. Patients with late Lyme neuroborreliosis manifest with headache, personality change, and cognitive decline after symptomatic infection and appropriate antibiotic therapy. Peripheral nerve biopsy in patients with acute and subacute neuritis may demonstrate perivasculitis mediated by cytotoxic suppressor CD8 cells [16] .
Fungi
Four fungal agents have a predilection for cerebral vessels, leading to vasculitis, particularly in immunocompromised and neutropenic hosts. Aspergillosis invades the CNS in disseminated infection and by contiguous extension from paranasal sinuses and orbital foci of infection, leading to headache, hyphal angiitis, with resultant large and small vessel thromboses, cerebral infarction, and mycotic aneurysm formation. Those with candidiasis and coccidioidomycosis demonstrate chronic meningitis, but may also have invasion of the cerebral vessels leading to vasculitis. Mucormycosis is a particularly aggressive fungal infection especially in poorly controlled diabetic individuals, which if unrecognized spreads from the nasopharynx and sinuses to the orbit, cavernous sinus, and brain, resulting in a necrotizing vasculitis of the cerebral vessels. Affected patients have unilateral headache, lethargy, periorbital swelling, proptosis, and ophthalmoplegia. Septic thrombosis of the cavernous sinus and internal carotid artery is suggested by vision loss. Diagnosis requires a high index of suspicion in a predisposed host.
Rickettsia
The life cycle of rickettsiae involves insect vectors and mammal reservoirs; humans are accidental hosts. The organism enters the skin as the infected tick feeds, and disseminates throughout the body to infect systemic and cerebral vascular endothelial cells. Two to 14 days after a tick bite, affected patients develop headache, constitutional symptoms and skin rash. Neurological involvement leads to mental change, meningismus, ataxia, seizures, hallucination, and focal cerebral deficits, progressing to delirium, stupor, and coma reflective of encephalitis. The diagnosis is confirmed by serological and antiendothelial antibody studies, and immunohistological and polymerase chain reaction of the skin lesion. The pathogenesis of cerebral vessel damage is caused by the combined effects of direct infection and associated immunological injury ascribed to the upregulation of cytokines and the production of anti-endothelial antibodies. Neuropathological studies in fatal cases show cerebral edema, angiitis of small and medium-sized blood vessels with microinfarcts, punctate hemorrhage and glial nodules consisting of enlarged endothelial cells, lymphocytes, and macrophages that contain rickettsiae by immunofluorescence.
Bacterial meningitis
Cerebral vasculitis is a known complication of acute septic meningitis caused by a number of bacterial agents, which reflect age and underlying host conditions. Purulent infection at the base of the brain leads to true vasculitis as a result of inflammatory cell infiltration of vessel walls as they traverse the subarachnoid space. The activation of cellular adhesion molecules, complement, platelet factors, cytokine products, reactive oxygen species, excitatory amino acids, and proteolytic enzymes contribute to vessel wall damage and vasculitis. The diagnosis of acute septic thrombosis should be suspected in the presence of headache, fever, meningismus, seizures, focal neurological signs, and increased intracranial pressure; and confirmed by CSF analysis. Brain magnetic resonance angiography and conventional angiography shows vessel wall abnormalities, focal dilations, supraclinoid internal carotid artery narrowing, and distal branch occlusions. The later involvement of cerebral veins leads to septic venous sinus thrombosis and thrombophlebitis.
Mycobacterium tuberculosis
Headache and vasculitis occur in the setting of tuberculous meningitis caused by miliary infection or rupture of an old tubercle. Most adult patients have obvious clinical signs of meningitis, including headache, meningismus, and fever, but some have no obvious clinical signs, and in these instances a high index of suspicion is necessary such as in elderly and immunocompromised individuals. Blood vessels that traverse the thick gelatinous basilar exudate develop inflammation, particularly small and medium-sized arteries, and occasionally capillaries and veins. The inflamed adventitia contains cells, tubercles, caseation necrosis, and occasional clumps of mycobacteria. Reactive subendothelial cells proliferate, leading to stenosis of the vascular lumina. The arteritis that ensues leads to cerebral ischemia and infarction, most commonly in the middle cerebral artery territory. All patients that test culture positive for tuberculous meningitis should be tested for HIV-1 exposure.
HIV
Necrotizing vasculitis and granulomatous angiitis have both rarely been described in the course of HIV infection. There are patients with GANS in association with HIV infection in whom there was no evidence of opportunistic infection [12] . Peripheral nerve vasculitis is often the first manifestation of HIV, but also occurs after AIDS has developed, and may be manifest as a symmetrical or overlapping MNM syndrome. The vascular inflammatory infiltrate usually consists of CD8 T cells and macrophages [17] . HIV antigens in affected patients have been shown in perivascular macrophages by electron microscopy and in-situ hybridization [18] . Pathological findings include necrotizing arteritis of the epineurial vessels similar to PAN, but without an emphasis of healed lesions in different stages of development. Cryoglobulinemia has also been described in several patients with HIV infection and MNM. Necrotizing vasculitis can be seen in muscle biopsies of patients with peripheral nerve vasculitis, and an examination of both muscle and nerve tissue in suspected patients also increases the yield of a diagnostic biopsy. Vasculitis with HIV infection is more commonly caused by secondary opportunistic infection or is seen in association with lymphoma.
Central nervous system vasculitis associated with amphetamine abuse
Cerebral vasculitis in association with drug abuse was first reported among 14 drug addicts who used multiple amphetamine drugs [19] . Necrotizing arteritis of the PAN type was found in cerebral arteries and arterioles at postmortem examination (Fig. 14) . 
Paraneoplastic vasculitis
Paraneoplastic neurological disorders are diseases of nervous system function that occur in association with cancer, but cannot be ascribed to metastases or direction infiltration of the nervous system by tumor. In two-thirds of affected patients, the neurological disorder generally precedes the diagnosis of the tumor, and the correct identification of the related neurological disorder directs a search for occult and potentially curable cancer. Necrotizing arteritis and microvasculitis have been described in association with anti-Hu associated paraneoplastic encephalomyelitis and sensory neuropathy [20] . The anti-Hu antibody, when present at high titers in the serum and CSF of affected patients, is a highly sensitive and specific marker for paraneoplastic encephalomyelitis and sensory neuropathy in association with occult small cell lung cancer. Patients develop multifocal neurological symptoms and signs that include headache, limb encephalitis, brain stem deficits, cerebellar incoordination, proprioceptive and tactile sensory loss leading to imbalance of stance and gait, pseudoathetosis, numbness and paresthesia, weakness, wasting, fasciculation, active tendon reflexes, Babinski signs, Hoffman signs, and clonus. Histopathological examination of the neuraxis reveals widespread neuronal degeneration, neuronal loss, and Wallerian fiber degeneration in the hippocampus, brainstem, cerebellum, spinal cord dorsal columns, dorsal root ganglia, and nerve roots, with perivascular collections of chronic inflammatory cells, also known as perivasculitis. Paraneoplastic encephalomyelitis should be suspected in patients with subacute sensory neuropathy, a history of cancer or suspected malignancy, weight loss, headache, mental change, and multifocal involvement of the nervous system with upper and lower motor neuron signs, central and peripheral sensory loss, CSF pleocytosis and elevated total protein and IgG content, contrast neuroimaging studies that reveal meningeal or perivascular enhancement, and muscle and nerve biopsy that demonstrates microvasculitis, Wallerian nerve fiber degeneration, or inflammatory myopathy.
Laboratory diagnosis
The laboratory diagnosis of vasculitis of the nervous system proceeds along a systematic framework of generally accepted principles with an extensive choice of recommended studies as described below.
General principles
There is general agreement on four principles in the diagnosis of vasculitis: First, vasculitis is a potentially serious disorder with a propensity for permanent disability as a result of tissue ischemia and infarction; recognition of the neurological manifestations is important in developing a differential etiological diagnosis. Second, undiagnosed and untreated, the outcome of vasculitis is potentially fatal. Third, a favorable response to an empiric course of immunosuppressive and immunomodulating therapy should never be considered a substitute for the absolute proof of the diagnosis of vasculitis. Fourth, histolopathological confirmation of vasculitis in the nervous system is essential for accurate diagnosis, such as by analysis of nerve and muscle biopsy tissue when PNS involvement is postulated, and by brain and meninges when there is CNS involvement.
Recommended laboratory evaluation of suspected vasculitis
The laboratory evaluation of vasculitis of the nervous system is summarized in Table 2 . The initial diagnosis of vasculitis commences with an investigation of possible associated serological markers in a given patient. The emergence of specific serological studies for many of the connective tissue diseases including vasculitis has transformed our concepts of autoimmune disease. However, their use should be guided by the clinical presentation and postulated etiological diagnosis to avoid excessive cost and spurious results.
Electrodiagnostic studies are useful in the initial investigation of systemic vasculitis, because they can identify areas of asymptomatic involvement and sites for muscle and nerve biopsy and distinguish the various neuropathic syndromes associated with peripheral nerve and muscle involvement. A wide sampling of nerves and muscles should be examined, both distal and proximal, using standard recording and needle electrodes for the performance of nerve conduction studies and needle electromyography at skin temperatures of 348C in comparison with normative data. Most patients with peripheral nerve vasculitis show evidence of active axonopathy acutely in an MNM pattern and over time in a distal symmetric or asymmetric pattern. Quantitative motor unit potential analysis can delineate whether proximal wasting and weakness are caused by myopathic or neurogenic disease.
CSF analysis, electroencephalography, and neuroimaging studies are integral to the diagnostic evaluation of most CNS disorders, including vasculitis. Properly performed, lumbar puncture carries a minimal risk and provides potentially useful information regarding possible underlying vasculitis so suggested by pleocytosis in excess of 5 cells/mm 3 , protein elevation greater than 100 mg/dl, and evidence of intrathecal synthesis of immunoglobulin and oligoclonal bands. Molecular genetic, immunoassay, and direct staining techniques to exclude spirochetal, fungal, mycobacterial and viral infections, as well as cytospin examination of CSF for possible malignant cells should be performed.
There are no typical electroencephalography findings in CNS vasculitis. Magnetic resonance imaging (MRI) is more sensitive than computed tomography, but both methods lack specificity in histologically confirmed cases. The most common MRI findings are multiple bilateral cortical and deep white matter signal abnormalities, and enhancement of the meninges after gadolinium. Magnetic resonance angiography and functional imaging of the brain provide complementary findings to conventional MRI. The former is useful in the evaluation of medium and large vessel disease, but misses fine vessel contours better seen on cut-film or digital subtraction angiography. The abnormal diffuse and focal perfusion patterns seen on single photon emissioncomputed tomography (SPECT) do not always correlate with neurological symptoms or distinguish vasculitic from non-vasculitic vasculopathy. Some authorities claimed that cerebral angiography showed diagnostic features, but that assertion was later modified. The beading of vessels is found in only approximately a third of patients with histologically confirmed CNS vasculitis, as well as in CNS infection, atherosclerosis, cerebral embolism, and vasospasm of diverse cause (Fig. 15) . Multiple microaneurysms, often seen on visceral angiography in systemic vasculitis, are distinctly rare in CNS vessels.
Brain and meningeal biopsy are still the gold standard for the diagnosis of CNS vasculitis, but false-negatives occur because of focal lesions and sampling errors. Radiographic studies that guide the biopsy site towards areas of abnormality probably improve the sensitivity, but this has not been formally studied. The risk of serious morbidity related to biopsy is less than 2.0% at most centers, which is probably less than the cumulative risk of an empiric course of long-term immunosuppressive therapy. There are no certain guidelines as to when to proceed to brain and meningeal biopsy. However, it would certainly be warranted if there were no other explanation for the progressive syndrome of fever, headache, encephalopathy, and focal cerebral signs, in association with CSF pleocytosis, and protein content elevation greater than 100 mg/dl, which is suggestive of GANS.
The importance of nerve and muscle biopsy in the diagnosis of vasculitis cannot be overemphasized. It can be approached with confidence when a neurologist or surgeon skilled in nerve and muscle biopsy techniques at centers performs the procedure with neuropathologists trained to process and examine the specimens for all of the diagnostic possibilities. The nerve and muscle should be clinically and electrophysiologically affected. However, the muscle should not be so affected, or endstage, as to preclude interpretation. A segment of the sural, superficial peroneal sensory, or femoral intermedius sensory nerve can be surgically removed without incurring a serious deficit, along with pieces of muscle tissue, respectively, from the soleus, peroneus brevis, or rectus femoris muscle, thereby providing potentially useful information regarding the severity of the underlying neuropathy and increasing the yield of vasculitic lesions (Fig. 16 ). Commercially available monoclonal and polyclonal antibodies directed against T-and B-cell subsets, macrophages, immunoglobulins, C3d, C5b-9 MAC proteins, cytokines and other inflammatory mediators, and main histocompatibility class I and II antigens add precision to the analysis of peripheral nerve specimens with suspected necrotizing and non-necrotizing peripheral nerve vasculitis [21] .
Immunopathogenesis
Early progress in the understanding of vasculitis took a major turn during a discussion of the paper by Kernohan and Woltman [15] on PAN. At that time, in 1938, there was no effective treatment and antemortem diagnosis was rarely possible. Harry Lee Parker conceptualized nerve and muscle biopsy when he commented 'It occurs to me that in any case in which polyarteritis nodosa may be suspected, it is advisable to take a biopsy from a peripheral nerve, muscle, or artery.'
The Second World War provided another opportunity for the advancement of our understanding of the blood supply of the peripheral nerves, and these findings in turn guided our thoughts on vasculitis. In 1943, Coers and Woolf [22] described the surgical approach for biopsy of the superficial peroneal sensory nerve and peroneus brevis muscle now performed routinely for vasculitis. Two years later, Sunderland [23, 24] provided a detailed account of neurovascular anatomy by performing dissection of amputated limbs after injection of India ink to opacify the vessels. His findings were summarized in a concluding statement: 'Each of the major nerves is generally abundantly vascularized throughout its entire length by a succession of vessels, which by their repeated division and anastomosis within the nerve outline an unbroken vascular net' (Fig. 17) .
Some nerves such as the median and ulnar nerve between the axilla and elbow and along the sciatic in the gluteal region had few or no entering nutrient vessels, but vascular insufficiency was still an unlikely occurrence as stated by Sunderland. Admittedly there are instances, although uncommon, in which one vessel supplies long stretches of a nerve without reinforcement, but it has been demonstrated in sectioned and injected material that even under such apparently adverse conditions of supply, the anastomosis is of such dimensions at the peripheral limits of the solitary channel that segmental ischemia caused by the blocking of such a single vessel is a remote possibility.
On the basis of such studies, there was no convincing evidence for the presence of watershed zones of poor vascular supply along major nerves of the arm or leg, a contention that has permeated the literature with regard to the clinical sequelae of vasculitis. Nonetheless, Dyck and coworkers [25] ascribed centrofascicular nerve fiber loss in a patient with necrotizing vasculitis to poor vascular perfusion along presumed watershed zones of the upper arm and proximal thigh regions. Almost a decade later, Moore and Fauci [26] ascribed flail weakness and mid-level sensory loss of the arms to vasculitis of the arteria nervorum, even though the patient was not studied pathologically.
It is now known that under normal circumstances, the nervous system is protected from systemic immunological reactions by the blood-brain and blood-nerve barriers. Tight junctions between neighboring cells and a paucity of micropinocytotic vessels are unique to the blood-brain barrier, and along with other local determi- system. They are potentially active participants in vasculitis, not simply passive targets of injury. They satisfy the criteria for an APC because of their native ability to express MHC class I molecules for interaction with cytotoxic T cells; and under certain conditions, they express MHC class II molecules and the necessary costimulatory factors to induce T-cell proliferation in vivo and in vitro. The function of vascular endothelial cells is regulated mainly by IL, TNF, and endotoxins derived from immigrant or resident mononuclear cells. Their action, by virtue of binding to specific receptors, is alteration of the transcription of an array of endothelial genes that programme cellular inflammatory secretion, the local expression of leukocyte adhesion molecules, the balance of prothrombotic and antithrombotic vascular functions, the synthesis of matrix molecules and their receptors, and the secretion of growth factors, secondary cytokines, and enzymes related to matrix degradation. The localization and propagation of leukocytes along vascular endothelial cells depend on the local production of IL-1, IL-6, and IL-8, the expression of cell adhesion molecules, namely integrins, selectins, and the immunoglobulin super-family molecules (intercellular cell adhesion molecule 1, vascular cell adhesion molecule 1, platelet-endothelial cell adhesion molecule 1) constitutively expressed or induced after cellular activation, and the expression of autoantigens such as ANCA and anti-endothelial cell antibodies. Other substances that contribute to vascular integrity include free radical nitric oxide, Von Willebrand factor, tissue plasminogen activator inhibitor, thrombomodulin, and platelet-activating factors.
Human mechanisms also contribute to the development of vasculitis and nervous system damage through complement-mediated injury of microvessels. The complement system is composed of 11 proteins that sequentially interact in the activated state to form an assembly of five proteins referred to as C5b-9 or MAC. The activation of C5b-9 along peripheral nerve microvessels leads to increased local permeability, edema, and inflammatory cell infiltration. Complement-mediated injury appears to be an important mechanism in the etiopathogenesis of inflammatory diabetic vasculopathy; however, the initiating factors are still speculative. One possibility is a defect in the expression of certain regulatory membrane proteins in the walls of microvessels, including complement receptor (CR10), decayaccelerating factor (CD55), membrane co-factor protein (CD46), and membrane inhibitor of reactive lysis (CD59), which normally protect cells by limiting the activation of the complement cascade.
Interest in the role of specific pathogenic autoantibodies has evolved over the past two decades as, for example, in our understanding of WG and related disorders in the elucidation of ANCA. The pathobiology of ANCA was understood through the use of animal models, human neutrophil studies, and monolayers of cultured human umbilical vein endothelial cells. MPO and PR3 antigens, so named for the patterns of staining of normal ethanolfixed neutrophils with indirect immunofluorescence, granular cytoplasmic ANCA, and perinuclear ANCA, were found to correlate with disease activity in WG and MPA, respectively. The MPO and PR3 antigens are accessible for binding with circulating ANCA and Fc receptors. ANCA-augmented chemotaxis and adhesion bring circulating neutrophils and mononuclear phagocytes into close contact with endothelial cells and induce neutrophil-mediated endothelial cell lysis and vascular permeability.
Treatment
Neurologists treating vasculitis must choose the sequence and combination among available immunosuppressant and immunomodulating therapies, recognizing the possible adverse effects.
A modern appreciation of the usefulness of corticosteroid preparations in systemic vasculitis was first reported in 1950 [27] . Untreated, patients with PAN had a 5-year survival rate of 10%; treatment with corticosteroids increased survival to 48% [28] . Although the effectiveness of corticosteroids is well established, there is uncertainty even among experts as to the optimal regimen. For example, in one analysis [29] , a sustained benefit in PAN was obtained in patients with a minimum equivalent dosage of 31 mg of prednisone a day for 7 months. The beneficial effects of corticosteroids are attributed to a multiplicity of effects on the cell and humoral immune system, including the inhibition of activated T and B cells, APC, and leukocytes at sites of inflammation, IFN-g, induced MHC class II expression, macrophage differentiation, pathogenic cytokine expression, complement interactions, and immunomodulating cell adhesion molecules.
The effectiveness of a daily oral regimen of cyclophosphamide and prednisone in WG was first reported by Fahey et al. [30] in 1954, and later by Fauci et al. [31] in 1971, and served as a template for the treatment of virtually all types of systemic vasculitis, including GANS until its long-term side-effects were appreciated in WG. Nonetheless, this alkylating agent is an important adjunct in the treatment of systemic vasculitis. It leads to preferential T-cell lysis resulting from the inhibition of hematopoietic precursors in the bone marrow.
Azathioprine is a purine analog that metabolizes to the cytotoxic derivative 6-mercaptopurine. It exerts favorable action in vasculitis by the inhibition of T-cell activation and T-cell-dependent antibody-mediated re-sponses. It is appropriate alterative therapy to corticosteroids and cyclophosphamide in systemic vasculitis. There are three drawbacks to its use. First, idiosyncratic side-effects, most often gastrointestinal and 'flu-like, occur in approximately 10% of patients and rarely necessitate permanent withdrawal of the medication. However, pancreatitis and gastritis severe enough to warrant hospitalization can occur. Second, bone marrow suppression occurs in nearly all patients, usually manifested by mild pancytopenia. Third, there is typically a long delay in the onset of the therapeutic effect of 3 months or more. Taking all these factors into account, most clinicians concur with the slow advancement of the dose over weeks, commencing with 50 mg a day and achieving maintenance levels of 2-3 mg/kg a day, with careful monitoring of liver and marrow function.
Intravenous immunoglobulin (IVIg) therapy has been widely used in the treatment of autoimmune neurological diseases, and warrants consideration as initial or adjunctive therapy in vasculitis of the PNS and as adjunctive therapy in CNS. This is because of its acknowledged salutary action through the action of blocking antibodies, the suppression of antibodymediated responses, the accelerated catabolism of pathogenic IgG antibodies, the suppression of pathogenic cytokines, and most of all, the inhibition of C5b-9 MAC-mediated cytolysis. The usual dosage is 400 mg/kg per day for 5 days once a month, after the determination of adequate renal clearance and the absence of IgA antibodies that can rarely promote anaphylaxis. A new manufacturing process that employs chromatographic steps in the intravenous immunoglobulin purification scheme yields a purer intravenous immunoglobulin product that more closely reflects the IgG subclass distribution found in plasma.
Conclusion
The comprehensive therapy of patients with vasculitis often requires the commitment of a multidisciplinary team of health professionals and caregivers to optimize recovery while initiating immunotherapy. Physical therapy and orthosis may be warranted for disabling motor and cognitive disorder impairments to maintain a range of motion and strength, to improve function status, and to maintain ambulation. Effective pain management may be an important aspect of their care, not only to provide overall wellbeing, but to permit more aggressive physiotherapy. Agents such as tricyclic antidepressants, gabapentin, mexiletine, opioids, clonazepam, and topical anesthetic creams have all been used with varying success. Finally, efforts should be made to limit the ischemic-enhancing effects of other conditions, such as with diabetes mellitus through improved glycemic control, the regulation of blood pressure and hyperlipidemia, alone or as a side-effect of concomitant corticosteroids, and the cessation of cigarette smoking.
